Simmons & Simmons advised Eisai on the divestment. Eisai S.A.S, the French subsidiary of Eisai Co., Ltd., has transferred its rights to Loxapac (loxapine) and Parkinane...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here